Who Owns Vertex Pharmaceuticals Stock?
NASDAQ: VRTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 2:35 PM ET
Ownership breakdown
- Held by institutions
- 98.00%
- Held by insiders
- 0.21%
- Institutional holders
- 2,432
- Institutions 98.0%
- Insiders 0.2%
- Public and other 1.8%
Who owns Vertex Pharmaceuticals stock?
Institutional investors own about 98.0% of Vertex Pharmaceuticals's shares, spread across 2,432 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.21% of VRTX.
The largest institutional holders are Capital World Investors (10.29%), Blackrock Inc. (9.50%) and Capital Research Global Investors (7.68%). Together, the top 10 institutions control 50.6% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their VRTX positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of VRTX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Capital World Investors | 26.12M | 10.29% | +2.9% |
| Blackrock Inc. | 24.11M | 9.50% | +0.6% |
| Capital Research Global Investors | 19.49M | 7.68% | -7.7% |
| Vanguard Capital Management LLC | 16.58M | 6.53% | +0.4% |
| State Street Corporation | 11.87M | 4.68% | +1.2% |
| Invesco Ltd. | 8.04M | 3.17% | +1.9% |
| JPMORGAN CHASE & CO | 6.52M | 2.57% | -7.3% |
| Geode Capital Management, LLC | 6.02M | 2.37% | -2.0% |
| Vanguard Portfolio Management LLC | 4.88M | 1.92% | -5.2% |
| Capital International Investors | 4.70M | 1.85% | -8.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of VRTX
| Fund | Shares | % Held |
|---|---|---|
| Growth Fund of America | 12.54M | 4.94% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 8.06M | 3.17% |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 6.58M | 2.59% |
| Investment Co of America | 6.27M | 2.47% |
| AMERICAN BALANCED FUND | 5.56M | 2.19% |
| Invesco QQQ Trust, Series 1 | 5.46M | 2.15% |
| Amcap Fund | 4.65M | 1.83% |
| iShares Trust-iShares Core S&P 500 ETF | 3.38M | 1.33% |
| NEW PERSPECTIVE FUND | 3.37M | 1.33% |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 3.29M | 1.30% |
Frequently asked questions
Who is the largest shareholder of Vertex Pharmaceuticals?
Capital World Investors is the largest institutional shareholder of VRTX, owning 10.29% of shares outstanding (26.12M shares) as of its latest 13F filing.
What percentage of Vertex Pharmaceuticals is owned by institutions?
Institutions own about 98.0% of VRTX shares and 98.2% of the public float.
How much of Vertex Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 0.21% of VRTX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.